SlideShare a Scribd company logo
Extemporaneous Compounding
Prepared By: Nishant Shrestha
M. Pharmacy (Clinical)
Extemporaneous compounding
• Extemporaneous compounding is defined as the timely preparation of
a drug product according to a physicians prescription, a drug formula,
or a recipe in which calculated amounts of ingredients are made into a
homogenous (uniform) mixture. Example: Captopril syrup Captopril
powder
• Extemporaneous compounding is done when certain medical needs of
individual patients cannot be met by the use of an approved
commercial drug product.
Reason and Purpose for Extemporaneous
Compounding
• Unavailable dosages, strengths and routes of commercial products
• Dilution of adult doses of medications to Pediatric/Geriatric strengths.
• Conversion of solid dosage forms to solutions or suspensions.
• Combination of topical dermatological products not available by the
manufacturer.
• Inactive ingredients of commercial products which may cause allergic
reactions in individuals.
Advantages of Extemporaneous
Compounding
Problems Encountered in Extemporaneous
Compounding
General Principles of Labelling
General Principles of Labelling
General Principles of Labelling
Quality Assurance and Safety of
Extemporaneous Preparation
• Pharmacist (or trained personnel) should prepare and dispense compounded products in a manner
that ensures product quality, safety and efficacy and in accordance with good compounding
practices, official standards and relevant scientific data and information (if such information
exists).
• Appropriate stability evaluation is performed or determined from the literature to establish reliable
expiry data to ensure that the finished preparations have their expected potency, purity, quality and
characteristics, at least until the labelled expiry date.
• There should be assurance that processes are always carried out as intended or specified and are
under control.
• The relevant master document should be selected and a product specific worksheet and label
should be prepared before starting preparation.
• Where a calculation is required, it should be independently checked by an appropriate second
person wherever possible.
• The check should be performed prior to preparation to minimize the chance of product wastage.
Use of suitable containers and correct
labelling
• Primary packaging of the product must be fit for purpose and adequately protect
the product from the environment whilst being compatible with the product.
• Ideally the product must be labelled with the necessary particulars, including any
special requirements for the safe handling or storage of the product:
• common name of product
• statement of the active ingredients expressed qualitatively and quantitatively per
dosage unit or for a given volume or weight
• dose and route of administration
• contents of the container by weight, volume or number of doses
• expiry date
• batch number
• name and address of patient
EXAMPLE:
Amiodarone hydrochloride oral liquid (Extemporaneous Preparation)
• Using a typical strength of 40 mg/mL
Amiodarone hydrochloride 200 mg tablets * 20
Ora-Plus 50mL
Ora-Sweet SF to 100 mL.
• Method guidance
• Tablets can be ground to a fine, uniformpowder in a pestle and mortar. A small amount of
Ora-Plus may be added to form a paste, before adding further portions of Ora-Plus up to
50% of the final volume. Transfer to a measuring cylinder. The Ora-Sweet can be used to
wash out the pestle and mortar before making the suspension up to 100% volume.
Transfer to an amber medicine bottle.
• Shelf-life
• 28 days refrigerated or at room temperature in amber glass. Shake the bottle.

More Related Content

What's hot

Labelling of the pharmaceuticals
Labelling of the pharmaceuticalsLabelling of the pharmaceuticals
Labelling of the pharmaceuticalsKalsoom Mohammed
 
Preparations in pharmacy of hospital
Preparations in pharmacy of hospitalPreparations in pharmacy of hospital
Preparations in pharmacy of hospital
Prof. Dr. Basavaraj Nanjwade
 
Incompatibility l1
Incompatibility l1Incompatibility l1
Incompatibility l1
Ahmad Ali
 
Pharmaceutical Suspensions
Pharmaceutical SuspensionsPharmaceutical Suspensions
Pharmaceutical Suspensions
Muhammad Adeel
 
Preparation of suppository
Preparation of suppositoryPreparation of suppository
Preparation of suppository
Saif Khan
 
Pharmaceutics - suspension
Pharmaceutics -  suspensionPharmaceutics -  suspension
Pharmaceutics - suspension
Areej Abu Hanieh
 
Drug Incompatibility.
Drug Incompatibility.Drug Incompatibility.
Drug Incompatibility.
Oyshe Ahmed
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
University Institute of Pharmaceutical Sciences
 
Tablets
TabletsTablets
Tablets
Sagar Savale
 
PHARMACEUTICAL INCOMPATIBILITIES
PHARMACEUTICAL INCOMPATIBILITIESPHARMACEUTICAL INCOMPATIBILITIES
PHARMACEUTICAL INCOMPATIBILITIES
Rupali Bhoje
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
Ramya priya
 
Quality Control Test For Suspensions
Quality Control Test For SuspensionsQuality Control Test For Suspensions
Quality Control Test For Suspensions
bhanu_biswas
 
Excipients
ExcipientsExcipients
Excipients
Protik Biswas
 
compounding and good practice
compounding and good practicecompounding and good practice
compounding and good practice
ShaikhSaniya2
 
The prescription
The prescriptionThe prescription
The prescription
vishvajitsinh Bhati
 
Powders and granules
Powders and granulesPowders and granules
Powders and granules
Prof. Dr. Basavaraj Nanjwade
 
Tablets
TabletsTablets
Tablets
Kiran Hameed
 
Ointments
OintmentsOintments
Ointments
smita choudhary
 

What's hot (20)

Labelling of the pharmaceuticals
Labelling of the pharmaceuticalsLabelling of the pharmaceuticals
Labelling of the pharmaceuticals
 
Preparations in pharmacy of hospital
Preparations in pharmacy of hospitalPreparations in pharmacy of hospital
Preparations in pharmacy of hospital
 
Incompatibility l1
Incompatibility l1Incompatibility l1
Incompatibility l1
 
1 3-compounding and dispensing
1 3-compounding and dispensing1 3-compounding and dispensing
1 3-compounding and dispensing
 
Pharmaceutical Suspensions
Pharmaceutical SuspensionsPharmaceutical Suspensions
Pharmaceutical Suspensions
 
Preparation of suppository
Preparation of suppositoryPreparation of suppository
Preparation of suppository
 
Pharmaceutics - suspension
Pharmaceutics -  suspensionPharmaceutics -  suspension
Pharmaceutics - suspension
 
Drug Incompatibility.
Drug Incompatibility.Drug Incompatibility.
Drug Incompatibility.
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
 
Tablets
TabletsTablets
Tablets
 
Capsule's
Capsule'sCapsule's
Capsule's
 
PHARMACEUTICAL INCOMPATIBILITIES
PHARMACEUTICAL INCOMPATIBILITIESPHARMACEUTICAL INCOMPATIBILITIES
PHARMACEUTICAL INCOMPATIBILITIES
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
 
Quality Control Test For Suspensions
Quality Control Test For SuspensionsQuality Control Test For Suspensions
Quality Control Test For Suspensions
 
Excipients
ExcipientsExcipients
Excipients
 
compounding and good practice
compounding and good practicecompounding and good practice
compounding and good practice
 
The prescription
The prescriptionThe prescription
The prescription
 
Powders and granules
Powders and granulesPowders and granules
Powders and granules
 
Tablets
TabletsTablets
Tablets
 
Ointments
OintmentsOintments
Ointments
 

Similar to Extemporaneous Compounding

Compounding
CompoundingCompounding
Compounding
Romit Subba
 
Ch 5. Compounding in hospital.pptx hospital
Ch 5. Compounding in hospital.pptx hospitalCh 5. Compounding in hospital.pptx hospital
Ch 5. Compounding in hospital.pptx hospital
7ReeshabhBele
 
Compounding in hospital.pptx
Compounding in hospital.pptxCompounding in hospital.pptx
Compounding in hospital.pptx
Archana Chavhan
 
Introduction.pdf
Introduction.pdfIntroduction.pdf
Introduction.pdf
Dr. Samia
 
PHARMACEUTICS.pptx
PHARMACEUTICS.pptxPHARMACEUTICS.pptx
PHARMACEUTICS.pptx
PlexDon
 
Quality and formulation of medicines
Quality and formulation of medicinesQuality and formulation of medicines
Quality and formulation of medicines
Saajida Sultaana
 
Sagar Veterinary drug delivery system ppt.
Sagar Veterinary drug delivery system ppt.Sagar Veterinary drug delivery system ppt.
Sagar Veterinary drug delivery system ppt.
Sagar Goda
 
Social pharmacy
Social pharmacySocial pharmacy
Social pharmacy
BikashAdhikari26
 
Solid.pptx
Solid.pptxSolid.pptx
Solid.pptx
ssuserb91f2d
 
Gutika
GutikaGutika
Rohit industry converted
Rohit industry convertedRohit industry converted
Rohit industry converted
ROHIT YADAV
 
Good Pharmacy Practice.ppt
Good Pharmacy Practice.pptGood Pharmacy Practice.ppt
Good Pharmacy Practice.ppt
SanjeevPandey284481
 
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmcccccccGood Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Sanjiv Pandey
 
Project work
Project workProject work
Project work
AnuragJha81
 
Dispensing of Prescription Rx & Ethic of Pharmacist with Patients
Dispensing of Prescription Rx & Ethic of Pharmacist with PatientsDispensing of Prescription Rx & Ethic of Pharmacist with Patients
Dispensing of Prescription Rx & Ethic of Pharmacist with Patients
Dashty Rihany
 
Bristy
BristyBristy
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshare
AsgharullahKhan
 
Chapter 9 compounding
Chapter 9 compoundingChapter 9 compounding
Chapter 9 compoundingrr0006
 
TOPIC 9 INTRODUCTION TO PHARMACY.pptx
TOPIC 9 INTRODUCTION TO PHARMACY.pptxTOPIC 9 INTRODUCTION TO PHARMACY.pptx
TOPIC 9 INTRODUCTION TO PHARMACY.pptx
BainunDali
 
GROUP # 2.pptx
GROUP # 2.pptxGROUP # 2.pptx
GROUP # 2.pptx
ShumailaQadir2
 

Similar to Extemporaneous Compounding (20)

Compounding
CompoundingCompounding
Compounding
 
Ch 5. Compounding in hospital.pptx hospital
Ch 5. Compounding in hospital.pptx hospitalCh 5. Compounding in hospital.pptx hospital
Ch 5. Compounding in hospital.pptx hospital
 
Compounding in hospital.pptx
Compounding in hospital.pptxCompounding in hospital.pptx
Compounding in hospital.pptx
 
Introduction.pdf
Introduction.pdfIntroduction.pdf
Introduction.pdf
 
PHARMACEUTICS.pptx
PHARMACEUTICS.pptxPHARMACEUTICS.pptx
PHARMACEUTICS.pptx
 
Quality and formulation of medicines
Quality and formulation of medicinesQuality and formulation of medicines
Quality and formulation of medicines
 
Sagar Veterinary drug delivery system ppt.
Sagar Veterinary drug delivery system ppt.Sagar Veterinary drug delivery system ppt.
Sagar Veterinary drug delivery system ppt.
 
Social pharmacy
Social pharmacySocial pharmacy
Social pharmacy
 
Solid.pptx
Solid.pptxSolid.pptx
Solid.pptx
 
Gutika
GutikaGutika
Gutika
 
Rohit industry converted
Rohit industry convertedRohit industry converted
Rohit industry converted
 
Good Pharmacy Practice.ppt
Good Pharmacy Practice.pptGood Pharmacy Practice.ppt
Good Pharmacy Practice.ppt
 
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmcccccccGood Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmccccccc
 
Project work
Project workProject work
Project work
 
Dispensing of Prescription Rx & Ethic of Pharmacist with Patients
Dispensing of Prescription Rx & Ethic of Pharmacist with PatientsDispensing of Prescription Rx & Ethic of Pharmacist with Patients
Dispensing of Prescription Rx & Ethic of Pharmacist with Patients
 
Bristy
BristyBristy
Bristy
 
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshare
 
Chapter 9 compounding
Chapter 9 compoundingChapter 9 compounding
Chapter 9 compounding
 
TOPIC 9 INTRODUCTION TO PHARMACY.pptx
TOPIC 9 INTRODUCTION TO PHARMACY.pptxTOPIC 9 INTRODUCTION TO PHARMACY.pptx
TOPIC 9 INTRODUCTION TO PHARMACY.pptx
 
GROUP # 2.pptx
GROUP # 2.pptxGROUP # 2.pptx
GROUP # 2.pptx
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Extemporaneous Compounding

  • 1. Extemporaneous Compounding Prepared By: Nishant Shrestha M. Pharmacy (Clinical)
  • 2. Extemporaneous compounding • Extemporaneous compounding is defined as the timely preparation of a drug product according to a physicians prescription, a drug formula, or a recipe in which calculated amounts of ingredients are made into a homogenous (uniform) mixture. Example: Captopril syrup Captopril powder • Extemporaneous compounding is done when certain medical needs of individual patients cannot be met by the use of an approved commercial drug product.
  • 3. Reason and Purpose for Extemporaneous Compounding • Unavailable dosages, strengths and routes of commercial products • Dilution of adult doses of medications to Pediatric/Geriatric strengths. • Conversion of solid dosage forms to solutions or suspensions. • Combination of topical dermatological products not available by the manufacturer. • Inactive ingredients of commercial products which may cause allergic reactions in individuals.
  • 5. Problems Encountered in Extemporaneous Compounding
  • 9. Quality Assurance and Safety of Extemporaneous Preparation • Pharmacist (or trained personnel) should prepare and dispense compounded products in a manner that ensures product quality, safety and efficacy and in accordance with good compounding practices, official standards and relevant scientific data and information (if such information exists). • Appropriate stability evaluation is performed or determined from the literature to establish reliable expiry data to ensure that the finished preparations have their expected potency, purity, quality and characteristics, at least until the labelled expiry date. • There should be assurance that processes are always carried out as intended or specified and are under control. • The relevant master document should be selected and a product specific worksheet and label should be prepared before starting preparation. • Where a calculation is required, it should be independently checked by an appropriate second person wherever possible. • The check should be performed prior to preparation to minimize the chance of product wastage.
  • 10. Use of suitable containers and correct labelling • Primary packaging of the product must be fit for purpose and adequately protect the product from the environment whilst being compatible with the product. • Ideally the product must be labelled with the necessary particulars, including any special requirements for the safe handling or storage of the product: • common name of product • statement of the active ingredients expressed qualitatively and quantitatively per dosage unit or for a given volume or weight • dose and route of administration • contents of the container by weight, volume or number of doses • expiry date • batch number • name and address of patient
  • 11. EXAMPLE: Amiodarone hydrochloride oral liquid (Extemporaneous Preparation) • Using a typical strength of 40 mg/mL Amiodarone hydrochloride 200 mg tablets * 20 Ora-Plus 50mL Ora-Sweet SF to 100 mL. • Method guidance • Tablets can be ground to a fine, uniformpowder in a pestle and mortar. A small amount of Ora-Plus may be added to form a paste, before adding further portions of Ora-Plus up to 50% of the final volume. Transfer to a measuring cylinder. The Ora-Sweet can be used to wash out the pestle and mortar before making the suspension up to 100% volume. Transfer to an amber medicine bottle. • Shelf-life • 28 days refrigerated or at room temperature in amber glass. Shake the bottle.